NSCLC STAGE III
Clinical trials for NSCLC STAGE III explained in plain language.
Never miss a new study
Get alerted when new NSCLC STAGE III trials appear
Sign up with your email to follow new studies for NSCLC STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo treatment tested for frail lung cancer patients
Disease control CompletedThis study tested whether combining a targeted form of radiation with an immunotherapy drug (durvalumab) is safe and effective for older or frail patients with stage III non-small cell lung cancer (NSCLC) who are not healthy enough for standard chemotherapy. The goal was to see i…
Matched conditions: NSCLC STAGE III
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope for inoperable lung cancer: experimental combo shows promise
Disease control CompletedThis study tested whether adding two new drugs (GFH018 and toripalimab) to standard chemotherapy and radiation could better control advanced, inoperable stage III lung cancer. It involved 65 patients who had not received prior treatment for this stage of cancer. The main goal was…
Matched conditions: NSCLC STAGE III
Phase: PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC